1.56

0.00% +0.00

Altamira Therapeutics Ltd (CYTO)

Panoramica Notizia Cronologia dei prezzi Perché CYTO Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.56

Aprire:

$1.54

Volume 24 ore:

20,122

Capitalizzazione di mercato:

$3.49M

Reddito:

$132.70K

Utile/perdita netta:

$-25.04M

Rapporto P/E:

-0.0755

EPS:

-20.6616

Flusso di cassa netto:

1 W Prestazione:

+7.59%

1M Prestazione:

+5.41%

6M Prestazione:

-72.14%

1 anno Prestazione:

-91.03%

Intervallo 1D:

$1.51

$1.56

Portata 52W:

$1.35

$23.60

Altamira Therapeutics Ltd Stock (CYTO) Company Profile

Nome

Altamira Therapeutics Ltd

Settore

Healthcare (1209)

Industria

Biotechnology (699)

Telefono

441-295-5950

Indirizzo

Clarendon House, 2 Church Street, Hamilton

Dipendente

Cinguettio

Prossima data di guadagno

2024-05-16

Ultimi documenti SEC

CYTO's Discussions on Twitter

Altamira Therapeutics Ltd Borsa (CYTO) Ultime notizie

Altamira Shareholders Approve Key Corporate Changes - TipRanks.com - TipRanks

TipRanks

Altamira Therapeutics Stock Surges on Positive Covid-19 Nasal Spray Data - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA ... - GlobeNewswire

GlobeNewswire

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA ... - Marketscreener.com

Marketscreener.com

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

GlobeNewswire Inc.

Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA ... - Yahoo Finance

Yahoo Finance

Altamira Therapeutics Ltd Azioni (CYTO) Dati Finanziari